Press release | 5th December 2007

E-WorkBook Goes Global with CDCO

Guildford United Kingdom, December 05, 2007 – IDBS is pleased to announce that the Centre for Drug Candidate Optimisation (CDCO), Monash University, has licensed the E-WorkBook Suite to centralise their research data. This is the first sale of the E-WorkBook Suite in Australia.

As a collaborative research centre within the Victorian College of Pharmacy at Monash University, the CDCO sought an application for the capture of both chemical and biological data generated by physiochemical and ADME studies of novel drug candidates. Providing discipline-specific extensions for handling the different data types generated, the E-WorkBook Suite provides one integrated framework for research data management throughout an entire organisation.

Susan Charman, Director at the CDCO, commented: “We were previously using traditional lab notebooks and wanted an electronic method of capturing, protecting and standardising data and reports. E-WorkBook’s flexible design means that it can be applied across multiple disciplines, supporting the capture of diverse research data and knowledge within one secure environment.” She added: “IDBS’ E-WorkBook Suite provides us with a tool to enable easy and secure data recording, storage and retrieval within the CDCO, which will, in turn, lead to improved efficiency and enhanced decision-making.”

Neil Kipling, founder and CEO of IDBS, commented: “With over 3,500 users worldwide, the CDCO is the latest organisation to recognise the significant value of using our E-WorkBook Suite. Our single framework approach, with domain-specific extensions, exactly maps the workflow that the CDCO and many other organisations are adopting.” He added: “It is deeply gratifying to know that research organisations worldwide recognise the value of our solutions.”

About CDCO

Established in 2003 as a cooperative research centre of the Victorian College of Pharmacy, Monash University, the CDCO is a unique venture that provides collaborative lead candidate optimisation in support of emerging drug discovery programs. Equipped with state of the art instrumentation and employing highly qualified and experienced scientists, the CDCO offers contemporary approaches and methodologies to address key issues associated with candidate selection and progression from drug discovery to development. Collaborative programs are commercially focused and specifically designed to meet the needs of both individual for-profit and not-for-profit organisations.

About IDBSContact us

More news

Webinar | November 30 | Managing the Journey from Process Development to Insight

In this session, you will learn how to build the right foundation to ensure confidence in the accuracy and availability of your data, understand how to get actionable insights from your bioprocess data to maximize cell culture productivity, and discover how out-of-the box workflows and integrations can curate a process data backbone that speeds time-to-insight with advanced data analytics and visualization tools.

Read more

IDBS Polar Insight

IDBS, a Danaher (NYSE:DHR) operating company, announced Polar Insight, bringing new advanced data analytics and visualization tools to the Polar BioPharma Lifecycle Management (BPLM) platform. Extracting valuable insights from process and quality data across the biopharmaceutical lifecycle is a time consuming and error prone process, requiring laborious manual work and multiple steps.

Read more

Skyland Analytics Acquisition

Global life sciences software company IDBS announces the acquisition of biopharmaceutical manufacturing data management and analytics software developer Skyland Analytics, in a move that will create the first BioPharma Lifecycle Management (BPLM) offering that supports therapies from early development through commercial manufacturing.

Read more

IDBS Acquires Skyland Analytics

Global life sciences software company IDBS announces the acquisition of biopharmaceutical manufacturing data management and analytics software developer Skyland Analytics, in a move that will create the first BioPharma Lifecycle Management (BPLM) offering that supports therapies from early development through commercial manufacturing. Skyland Analytics is best known for its Skyland PIMS™ software which seamlessly combines product, process, and patient data across the biopharma lifecycle and supply chain, providing insights that accelerate process understanding and ensure product quality.

Read more